Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.

Y-T Kim1, J S Byun, J Kim

  • 1Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. yongtkim@plaza.snu.ac.kr

Hepato-Gastroenterology
|March 13, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recognition and management of dermatologic complications from interventional radiology procedures.

Diagnostic and interventional imaging·2019
Same author

Functional characterisation of two phytochelatin synthases in rice (Oryza sativa cv. Milyang 117) that respond to cadmium stress.

Plant biology (Stuttgart, Germany)·2019
Same author

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.

Journal of neuro-oncology·2018
Same author

Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.

Diagnostic and interventional imaging·2017
Same author

Hemorrhage risk with transjugular intrahepatic portosystemic shunt (TIPS) insertion at the main portal vein bifurcation with stent grafts.

Diagnostic and interventional imaging·2017
Same author

Onion (Allium cepa L.) peel extract (OPE) regulates human sperm motility via protein kinase C-mediated activation of the human voltage-gated proton channel.

Andrology·2017

Hepatolithiasis increases cholangiocarcinoma risk. Key predictors include age over 40, weight loss, elevated alkaline phosphatase, low albumin, CEA over 4.2 ng/mL, and liver stone location in the right or both lobes.

Area of Science:

  • Hepatobiliary Medicine
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hepatolithiasis is a known risk factor for cholangiocarcinoma.
  • Early detection of cholangiocarcinoma in patients with hepatolithiasis is challenging.
  • Identifying predictive factors is crucial for timely diagnosis and intervention.

Purpose of the Study:

  • To identify clinical characteristics that predict cholangiocarcinoma in patients with hepatolithiasis.
  • To compare patients with hepatolithiasis and concurrent cholangiocarcinoma (group HC) against those with hepatolithiasis alone (group H).

Main Methods:

  • Retrospective study comparing 40 patients in group HC with 73 patients in group H.
  • Analysis of clinical characteristics including age, weight loss, serum markers, and hepatolithiasis location.

Related Experiment Videos

  • Receiver Operating Characteristic (ROC) curve analysis for serum CEA levels.

    • Main Results:

    • Group HC patients were older (56.7 vs 49.2 years) and experienced more weight loss (51.5% vs 5.5%).
    • Elevated serum alkaline phosphatase (181 vs 426 IU/L) and higher prevalence of hepatolithiasis in the right or both lobes (72.5% vs 50.6%) were observed in group HC.
    • Serum CEA cutoff of 4.2 ng/mL showed 67.6% sensitivity and 90.5% specificity for cholangiocarcinoma detection.

    Conclusions:

    • Cholangiocarcinoma should be suspected in hepatolithiasis patients over 40 with specific clinical indicators.
    • Key predictive factors include long stone history, weight loss, elevated alkaline phosphatase, low albumin, CEA > 4.2 ng/mL, and involvement of the right or both liver lobes.
    • These findings aid in early detection and management of cholangiocarcinoma in the context of hepatolithiasis.